MedGenome

MedGenome is a global leader in genomics-based diagnostics and research services, offering over 1,300 genetic tests spanning oncology, rare diseases, prenatal diagnostics, neurology, and infectious diseases. Founded in 2013 and headquartered in Bangalore, India, MedGenome operates across three core business lines: genomic diagnostics for clinical use, genomic research services for pharmaceutical and biotech partners, and drug discovery solutions powered by real-world genomic data. The company provides DNA sequencing, bioinformatics analysis, and multiomics services to healthcare providers, research institutions, and biopharma companies globally. Its US arm was rebranded as Signios Biosciences in 2025, offering sequencing and multiomics services from Foster City, California.